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Abstract Sphingosine-1-phosphate (S1P) receptor sub-
type 1 (S1P1), a G-protein coupled receptor (GPCR), regu-
lates many biological activities of endothelial cells (ECs).
In this report, we show that S1P1 receptors are present in
the nuclei of ECs by using various biochemical and micro-
scopic techniques such as cellular fractionation, immuno-
gold labeling, and confocal microscopic analysis. Live cell
imaging showed that plasma membrane S1P1 receptors are
rapidly internalized and subsequently translocated to
nuclear compartment upon S1P stimulation. Utilizing mem-
brane biotinylation technique further supports the notion
that nuclear S1P1 receptors were internalized from plasma
membrane S1P1 after ligand treatment. Moreover, nuclear
S1P1 is able to regulate the transcription of Cyr61 and
CTGF, two growth factors functionally important in the
regulation of vasculature. Collectively, these data suggest a
novel S1P–S1P1 signaling axis present in the nuclear com-
partment of endothelial cells, which may regulate biologi-
cal responses of endothelium.
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Abbreviations
S1P Sphingosine-1-phosphate




GPCR G-protein coupled receptor
HUVECs Human umbilical vein endothelial
cells
ECs Cultured endothelial cells
GFP Green Xuorescent protein
Cyr61 Cysteine-rich angiogenic protein 61
CTGF Connective tissue growth factor
NLS Nuclear localization sequences
Introduction
Sphingosine-1-phosphate (S1P), a serum-borne bioactive
lipid mediator secreted by activated platelets (Yatomi et al.
1995), regulates a variety of cellular responses including
proliferation, survival, cytoskeletal remodeling, adhesion,
and chemotaxis (Wu et al. 1995, 1999, 2008; Spiegel et al.
1998; Lee et al. 1999, 2001, 2006; ). In endothelial cells
(ECs), most of these responses are mediated by the S1P
receptor subtype 1 (S1P1, old nomenclature EDG-1), a
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(GPCRs) (Lee et al. 1999, 2001, 2006; Paik et al. 2001).
The S1P1 was cloned from cultured human umbilical vein
endothelial cells (HUVECs) stimulated with the tumor pro-
moter phorbol 12-myristate 13-acetate (PMA) (Hla and
Maciag 1990). Subsequently, S1P1 was shown to activate
mitogen-activated protein kinase (MAPK or ERK1/2) and
phospholipase A2 (PLA2) and inhibit adenylate cyclase via
Gi heterotrimeric G proteins (Lee et al. 1996). In addition,
recent studies suggest that S1P/S1P1 signaling plays an
important role in regulating blood vessel development and
maturation (Lee et al. 1999; Liu et al. 2000). For example,
in cultured ECs, S1P/S1P1 signaling regulates endothelial
survival, migration, cytoskeletal reorganization, and adher-
ens junction formation, all of which result in endothelial
morphogenesis to form capillary-like structures in vitro
(Lee et al. 1999, 2001, 2006). Furthermore, deletion of
S1P1 results in embryonic lethality in transgenic mice due
to a defect in the vasculature (Liu et al. 2000). These results
together suggest that S1P/S1P1 signaling plays a critical
role in neo-vessel formation and vasculature maintenance.
Ligand-induced internalization and intracellular traYck-
ing of GPCRs is thought to be important in the regulation of
signal transduction and biological functions mediated by
GPCRs. The spatiotemporal relationship of S1P-induced
intracellular traYcking of the S1P1 receptor was previously
examined in HEK293 cells heterologously expressing
green Xuorescent protein (GFP) tagged S1P1 receptor
(HEK293S1P1GFP) (Liu et al. 1999). In that study, it was
shown that S1P1 receptors were internalized into endosomal
compartments and subsequently recycled back to the plasma
membrane after S1P stimulation (Liu et al. 1999). However,
the relevance of this plasma membrane–endosome–plasma
membrane traYcking route of S1P1 receptors has not yet
been characterized in a truly physiological setting. Moreover,
the functional signiWcance of S1P1 internalization/traYcking
in response to S1P stimulation is presently unknown.
There is increasing evidence suggesting nuclear locali-
zation of GPCRs (Marrache et al. 2005; Cook et al. 2006;
Gobeil et al. 2002, 2003a, b; Lee et al. 2004; Pickard
et al. 2006; Liao et al. 2007). However, the underlying
mechanisms and functional signiWcance of nuclear-local-
ized GPCRs are poorly understood. In this report, we
show that S1P1 is present in the nuclear compartment of
ECs. Also, we demonstrate that S1P treatment results in
nuclear translocation of S1P1 receptors. Furthermore, we
demonstrate that the nuclear S1P–S1P1 signaling axis is
able to activate transcriptional activities in endothelial
cells. This study presents evidence for the Wrst time show-
ing the functional signiWcance of nuclear-localized S1P1
in ECs. These data together suggest that nuclear S1P1




Sphingosine-1-phosphate (Biomol) was dissolved in fatty
acid-free bovine serum albumin (BSA, Sigma, 0.4%).
Mouse-derived S1P1 monoclonal antibody (E1-49) was gen-
erated by conventional hybridoma technology using bacteria-
expressed S1P1 as an immunogen (Lee et al. 2006). E1-49
was shown to speciWcally react with the human S1P1 receptor
by immunostaining, immunoblotting, and immunoprecipita-
tion (Lee et al. 2006). Polyclonal rabbit anti-GFP antibody
was purchased from Molecular Probes. Monoclonal mouse
anti-calnexin was purchased from BD Transduction Labora-
tories. Mouse anti-human Na+/K+ ATPase (6F) came from
the Development Studies Hybridoma bank. Rabbit anti-
human Lamin A/C was purchased from Cell Signaling. Rab-
bit anti-human Rab4 was purchased from Chemicon. Other
reagents, unless otherwise speciWed, were from Sigma.
Cell culture
HUVECs were purchased from Cambrex Bioproducts.
HUVECs and HEK293 stably expressing GFP-tagged S1P1
(S1P1GFP) or GFP polypeptides were cultured as previously
described (Lee et al. 1999, 2001, 2006; Liu et al. 1999).
Cell fractionation and nuclei isolation
HUVECs were collected between passages 6–13 at »80%
conXuency unless otherwise stated. Isolation of nuclei was
achieved by using the hypotonic/Nonidet P-40 lysis method
(Kaufmann et al. 1983; Gobeil et al. 2002; Lee et al. 2004;
Liao et al. 2007). BrieXy, cultures were rinsed twice with ice-
cold PBS and collected with cell scrapers. Cells (5 £ 106)
were resuspended in 0.5 ml of hypotonic/Nonidet P-40 buVer
(10 mM Tris, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.5%
Nonidet P-40) and incubated on ice for 5 min. After centri-
fuging at 500g for 5 min, nuclear pellets were washed twice
with 0.5 ml of hypotonic/Nonidet P-40 buVer. The morpho-
logical integrity of isolated nuclei (> 90%) was assessed by
light microscopy after trypan blue staining. The purity of
subcellular fractions was routinely veriWed by immunoblot-
ting with antibodies speciWc for markers of diVerent subcel-
lular organelles, e.g., CD61 and Na+/K+ ATPase for the
plasma membrane, calnexin for the endoplasmic reticulum,
Rab4 for the endosome, and lamin A/C for the nucleus.
Immunoprecipitation and immunoblotting
Cellular or nuclear extracts were prepared with TBST/OG
buVer (10 mM Tris-HCl, pH 8.0, 0.15 M NaCl, 10 mM
MgCl2, 1% Triton X-100, 60 mM n-octyl -D-glucopyrano-123
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incubated with anti-S1P1 at 4°C overnight. Subsequently,
the immunocomplexes were precipitated by protein-A
beads at 4°C for 1 h. After washing, precipitated polypep-
tides were released by boiling in double-strength Laemmli
SDS-sampling buVer (4.6% (w/v) SDS, 10% (v/v) -
mercaptoethanol, 20% (w/v) glycerol, 95.2 mM Tris-HCl,
pH 6.8, 0.01% (w/v) bromphenol blue) at 95°C for 5 min
and resolved with SDS-PAGE. The electrophoretically sep-
arated polypeptides were transferred to nitrocellulose mem-
brane, blocked in 5% non-fat dry milk (LabScientiWc), and
incubated with the indicated primary antibodies on a rotary
shaker at 4°C overnight. After washing, the blots were
incubated with HRP-conjugated second antibodies and
detected with Enhanced Chemiluminescence Reagent
(ECL) (Amersham).
Immunostaining and confocal microscope analysis
Cells were cultured in 35-mm glass bottom dishes (Mat-
Tek) and serum-starved in M199 medium for 2 h (for
HUVECs) or in DMEM supplemented with 0.05% FBS for
24 h (for HEK293). Cells were then stimulated with S1P
(200 nM) for various times, Wxed with 4% paraformalde-
hyde, and permeabilized with 0.25% Triton X-100. S1P1
receptors were stained with the mouse E1-49 antibody
(1:1,000 dilutions), followed by staining with Alexa488-
conjugated goat anti-mouse antibody (1:1,000 dilutions).
GFP-tagged S1P1 polypeptides (Lee et al. 1998; Liu et al.
1999) were directly visualized with an Axiovert 200 M epi-
Xuorescence microscope (Carl Zeiss). Confocal micro-
scopic analysis was carried out as previously described
(Lee et al. 1999; Liu et al. 1999; Wang et al. 2008).
Quantitative nuclear run-oV transcription assay
Nuclear run-oV transcriptional assays were performed
essentially as described (Rolfe and Sewell 1997; Li and
Chaikof 2002; Green and Bender 2000). Nuclei (2 £ 106)
were collected from HUVECs stimulated with or without
S1P (1 M, 1 h) and suspended in 200 l of DEPC-treated
water. The nuclear fraction (150 g proteins) was mixed
with an equal volume of 2 £ reaction buVer (10 mM Tris-
HCl, pH 8.0, 5 mM MgCl2, 0.3 M KCl, 1 mM each of ATP,
CTP, GTP, and UTP) containing RNase inhibitor (6 U/sam-
ple, Promega). Transcription was carried out at 30°C for
2 h in the presence or absence of S1P (1 M) with gentle
shaking. The transcription reaction was then terminated by
the addition of DNase I (24 g/sample) at 30°C for 10 min.
Subsequently, 200 l of SDS-containing buVer (5% SDS,
0.5 M Tris-HCl, pH 7.4, 0.125 M EDTA) was added and
proteins were digested by the addition of proteinase K
(200 g/sample). RNAs were then isolated using STAT-60
reagent (Tel-Test Inc.) according to the manufacturer’s
instructions. One microgram of RNAs was reverse-tran-
scribed with the oligo-dT15 primer (Roche Applied Sci-
ence) by using M-MLV reverse transcriptase (Promega) for
Fig. 1 Nuclear localization of S1P1 receptor. a HUVECs
(5 £ 106 cells) were used to isolate nuclear (N) and non-nuclear (S, the
500g supernatant after cellular disruption in lysis buVer) fractions as
described in Sect. “Materials and methods”. Extracts were immuno-
precipitated with anti-S1P1 followed by immunoblot with anti-S1P1
(top panel). Second–sixth panels 50 g of each fraction were probed
with marker antibodies; e.g., CD61 and Na/K ATPase (plasma mem-
brane), calnexin (Cal, endoplasmic reticulum), Rab4 (endosome), and
lamin A/C (Lam A/C, nuclei). b Nuclear (N) and non-nuclear (S) frac-
tions were prepared from HEK293S1P1GFP and HEK293GFP cells,
followed by immunoblotting with anti-GFP. Note that S1P1GFP poly-
peptides were present in both nuclear and non-nuclear fractions,
whereas GFP were only present in the non-nuclear fraction. c Nuclei
were isolated from HEK293S1P1GFP and HEK293GFP cells. The nu-
clear extracts were then precipitated with anti-GFP followed by immu-
noblot with anti-GFP (top panel). Second–forth panels 50 g of
extracts were immunoblotted with marker antibodies123
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sion was performed with 1 l (or 20 ng) of reverse-tran-
scribed cDNAs in a total volume of 20 l of reaction
mixture containing 200 nM of each primer, 0.2 mM of each
dNTP and 1 unit of Taq Polymerase (Promega). Reactions
were performed using the Gene Amp 9700 PCR System
(Applied Biosystems). The PCR conditions were 30 cycles
of denaturation at 95°C (30 s), annealing at 58°C (30 s),
and extension at 72°C (30 s). AmpliWed PCR products were
analyzed by electrophoresis on a 1.5% agarose gel. PCR
primer pairs used were: human Cyr61, (sense) cctcggctgg
tcaaagttac, (antisense) aggctccattccaaaaacag; human CTGF:
(sense) aaggtgtggctttaggagca, (antisense) tcttgatggctggaga
atgc; human actin: (sense) aaactggaacggtgaaggtg, (antisense)
tcaagttgggggacaaaaag.
Results
S1P1 receptors are present in the nuclear compartment
To examine whether S1P1 receptors were located in the
nuclear compartment, nuclei were isolated from normally
growing HUVECs by the well-established nuclear isolation
method utilizing NP-40 lysis buVer. The purity of isolated
nuclei was conWrmed by the absence of markers for the
plasma membrane, endosome, and endoplasmic reticulum
(Fig. 1a). For example, CD61, Na/K ATPase, Rab4, and
calnexin were present in the supernatant fraction after 500g
centrifugation, which collectively represents the non-
nuclear fraction. In contrast, nuclear lamin A/C polypep-
tides were only detected in the puriWed endothelial nuclear
fraction. Importantly, S1P1 receptors were clearly detected
in the isolated endothelial nuclei (top panel, Fig. 1a). In
addition, it was previously shown that the GFP-tagged S1P1
(S1P1GFP) exhibits the same characteristics of S1P binding
and signal transduction as the wild-type S1P1 (Liu et al.
1999). Similar to ECs, a signiWcant amount of S1P1GFP
polypeptides was detected in the nuclei of
HEK293S1P1GFP cells (Fig. 1b). In contrast, GFP poly-
peptides were only observed in the non-nuclear fraction of
control HEK293GFP cells (Fig. 1b). The lack of contami-
nated polypeptides from other cellular compartments (e.g.,
Na/K ATPase and calnexin; middle two panels, Fig. 1c)
suggests that the presence of S1P1 receptors in the nuclear
compartment is not an artifact of isolation.
The nuclear presence of S1P1 in ECs was veriWed by
immunogold labeling followed by electron microscope analy-
sis (Fig. 2). Quantitative analysis shows that there are
1.28 § 0.12 (n = 11) and 0.94 § 0.10 (n = 14) gold particles/
m2 in the nuclei and plasma membrane of anti-S1P1 stained
ECs. The immunogold labeling is speciWc, because there are
0.16 § 0.03 (n = 10) and 0.23 § 0.09 (n = 11) gold particles/
m2 in the nuclei and plasma membrane of ECs stained with
control isotypical IgG2b (Fig. 2; P < 0.001, t test).
In addition, confocal microscope analysis of the isolated
nuclei of HEK293S1P1GFP cells shows a punctate distri-
bution pattern of S1P1GFP polypeptides in the isolated
nuclei (panels a–e, Fig. 3). In the experiments shown with
normal growing HEK293S1P1GFP cells at 80% conXu-
ency, 29 § 11% (n = 6) of the isolated nuclei were positive
for S1P1GFP polypeptides. Collectively, these data suggest
that the nuclear presence of S1P1 receptors is a truly physi-
ological phenomenon.
S1P treatment results in nuclear translocation of S1P1 
receptors
We utilized the immunoXuorescent microscopic analysis to
examine whether S1P stimulation induces nuclear translo-
Fig. 2 Immunogold detection 
of nuclear S1P1 in ECs. HU-
VECs were incubated with anti-
S1P1 (left) or isotypical mouse 
IgG2b (right) followed by gold-
particle conjugated secondary 
antibody as described (Mednieks 
et al. 1987; Wang et al. 1997). 
Note that immunogold labeling 
shows that S1P1 are present both 
in plasma membrane (top) and 
nuclear compartments (bottom). 
Arrows gold particles, arrow-
heads nuclear envelop. Scale 
bar = 0.226 m123
Histochem Cell Biol (2009) 131:239–249 243cation of the S1P1 receptor (Fig. 4). HEK293S1P1GFP
cells were synchronized at the quiescent state by serum-
starvation in DMEM containing 0.05% FBS for 24 h.
S1P1GFP polypeptides were primarily located at the plasma
membrane of the serum-starved cultures (upper left panel,
Fig. 4a). Addition of S1P induced rapid internalization of
S1P1GFP which formed an intracellular dot-like distribu-
tion pattern (lower left panel, Fig. 4a). At 30 min after S1P
stimulation, S1P1GFP polypeptides were mainly redistrib-
uted to the nuclear regions (upper right panel, Fig. 4a). Two
hours after S1P addition, S1P1GFP had completely returned
to the plasma membrane (lower right panel, Fig. 4a). In
contrast, GFP polypeptides were evenly distributed in the
cytoplasm of control HEK293GFP cells and exhibited no
apparent redistribution after S1P addition (data not shown).
Furthermore, three-dimensional Z-section analysis of con-
focal images shows that S1P1GFP polypeptides are mainly
relocated to the nuclear envelop region after S1P stimula-
tion (Fig. 4b).
Similarly, S1P stimulation induces nuclear localization
of S1P1 receptors in ECs (Fig. 5a). HUVECs undergo apop-
tosis by overnight serum starvation. Thus, cultured
HUVECs were subjected to partial synchronization by plat-
ing (1 £ 105 cells per 35-mm dish) for 3 days followed by
serum-starvation for 2 h at 37°C with serum-free M199
medium. After stimulation with or without S1P, cells were
Wxed and immunostained with monoclonal S1P1 antibody.
The S1P1 receptors were observed at plasma membrane and
cytoplasm in these partially synchronized ECs in the
absence of S1P stimulation (small arrows, upper right
panel, Fig. 5a). In sharp contrast, S1P1 receptors were
found in the nuclear regions in more than 80% of ECs after
S1P stimulation (large arrows, middle right panel, Fig. 5a).
The anti-S1P1 immunostaining was shown to be speciWc,
because the Xuorescent signal was barely detected in the
absence of anti-S1P1 (lower right panel, Fig. 5a). In addi-
tion, anti-S1P1 immunogold labeling showed that S1P1
receptors were signiWcantly relocated to nuclear envelop
region after S1P stimulation (arrows, lower panel, Fig. 5b).
There were 5.58 § 2.18 (n = 17) and 1.49 § 1.22 (n = 16)
gold particles/m2 in the nuclear envelop regions of ECs
treated with or without S1P, respectively (P < 0.001, t test).
These results together suggest that ligand stimulation is
capable of inducing the relocation of S1P1 receptors to the
nuclear compartment.
We next utilized the live cell imaging technique to
examine the ligand-induced intracellular traYcking and
nuclear translocation of S1P1 receptors in
HEK293S1P1GFP cells (Fig. 6). S1P1 receptors were
mainly located at plasma membrane of serum starved
HEK293S1P1GFP cells (arrows at 0 time, Fig. 6) and
immediately internalized into cytoplasmic compartments
after S1P addition (arrows at 0.5 and 1.0 min, Fig. 6). At
10 min after S1P treatment, S1P1 receptors were clearly
detected in the nuclear compartment (arrows at 10 min,
Fig. 6), and maintained in the nuclei up to 60 min after S1P
stimulation. Subsequently, S1P1 receptors were returned to
the plasma membrane. The ligand-induced intracellular
traYcking of S1P1 receptors is shown in a real-time movie
in Supplemental data 1. In a control, S1P1 receptors
remained at the plasma membrane and showed no detect-
able translocation for the 2-h imaging period in the absence
of S1P treatment (data not shown).
Fig. 3 Confocal microscopy analysis of S1P1 in isolated nuclei. Nu-
clei were isolated from HEK293S1P1GFP cells (Lee et al. 1998; Liu
et al. 1999) and analyzed by a confocal microscope (Lee et al. 1999;
Liu et al. 1999; Wang et al. 2008) (Panels a–e) or a Xuorescent micro-
scope (Axiovert 200M, Zeiss) (panels f–i). Panels a, c S1P1GFP local-
ization in isolated nuclei; panel b phase contrast image; panel d
propidium iodine stained nuclei; panel e merged image of panels c and
d. Panels f, g nuclei of HEK293S1P1GFP cells; panels h and i nuclei
of HEK293GFP cells. Panels f, h Xuorescent images; panels g, i
DAPI-stained nuclei. Scale bars in panels i (for panels a, b, f–i) and e
(for panels c–e) = 20 m. Images are representative of three experi-
ments with identical results123
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nique to conWrm that nuclear S1P1 receptors were translo-
cated from plasma membrane. HEK293S1P1GFP cells
were labeled with cell impermeable Sulfo-NHS-SS-Biotin
reagent (Pierce) at 4°C for 20 min. Cells were then sepa-
rated into nuclear and non-nuclear fractions. As shown in
Fig. 7a, only the plasma membrane S1P1 receptors were
biotin-labeled, whereas nuclear S1P1 receptors were not
Fig. 4 S1P induces nuclear localization of S1P1 receptors. a Serum-
starved HEK293S1P1GFP cells were treated with or without S1P
(200 nM) for various times. The intracellular traYcking of S1P1GFP
polypeptides was visualized by a confocal microscopy. Note that S1P1
receptors were mainly located at the plasma membrane at serum-
starved cells, and were rapidly internalized into intracellular compart-
ments (S1P, 10 min). After S1P stimulation for 30 min, S1P1 receptors
are translocated to nuclear compartment. Two hours later, S1P1 are re-
turned to the plasma membrane. Dashed circles demarcate the cell nu-
clei. b After serum starvation, HEK293S1P1GFP cells were stimulated
with S1P (100 nM) for 30 min. The nuclear localization of S1P1GFP
receptors were analyzed by a confocal microscope (FV1000, Olym-
pus). Note that S1P1GFP polypeptides were translocated to the nuclear
regions (DAPI-stained, blue colored) after S1P stimulation. Right and
bottom strips the three-dimensional Z-stacks of images, sectioned
through areas pointed by arrow and arrowhead, respectively. Note that
S1P1GFP polypeptides mainly locate at nuclear envelop. Scale bars in
panels a and b are 14 and 15.7 m, respectively
Fig. 5 S1P induces nuclear translocation of S1P1 in ECs. a HUVECs
were stimulated in the absence (upper panels) or presence (middle pan-
els) of S1P (100 nM, 60 min), followed by immunostaining with anti-
S1P1 (right panels). Lower panel, immunostain was performed without
anti-S1P1 primary antibody. Note that the S1P1 receptors were detected
at cell membrane in the absence of S1P stimulation (small arrows). In
sharp contrast, S1P1 receptors relocated to nuclear regions in more than
80% of ECs after S1P stimulation (large arrows). The anti-S1P1
immunostaining is speciWc, because the Xuorescent signal was barely
detected in the absence of anti-S1P1. b HUVECs were plated for 3 days
followed by serum-starvation for 2 h at 37°C with serum-free M199
medium. After stimulation with (low panel) or without (upper panel)
S1P (100 nM, 30 min), cells were immunogold labeled with S1P1 anti-
body. Note that S1P treatment signiWcantly induces the translocation of
S1P1 receptors to nuclear envelop regions (arrows, lower panel). There
are 5.58 § 2.18 (n = 17) and 1.49 § 1.22 (n = 16) gold particles/m2
in the nuclear envelop regions of ECs treated with or without S1P,
respectively (P < 0.001, t test). Arrows gold particles, arrowheads nu-
clear envelop, Nu nuclei. Scale bars in panels a and b are 34 and
0.142 m, respectively123
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nuclear nor non-nuclear Ran polypeptides (Ran locate at
cytoplasm and nuclei) were biotinylated (compare second
and fourth panels, Fig. 7a). This result indicates that the
biotinylation condition exclusively labels the extracellular
domains of plasma membrane polypeptides.
Subsequently, biotin-labeled cultures were washed and
incubated at 37°C in the presence or absence of S1P for
various times. Cell nuclei were prepared, solubilized, and
incubated with avidin beads to isolate biotinylated polypep-
tides. As shown in Fig. 7b, there are no biotin-labeled S1P1
receptors observed in the isolated nuclei in the absence of
S1P treatment (top panel, Fig. 7b). In sharp contrast, the
biotinylated S1P1 receptors were clearly detected in the iso-
lated nuclei at 10 min after S1P stimulation (top panel,
Fig. 7b). In a parallel control immunoblot, nuclear S1P1
polypeptides were shown to be quantitatively increased
after S1P stimulation (second panel, Fig. 7b). Together,
these data suggest that the nuclear S1P1 was translocated
from plasma membrane after ligand stimulation.
Nuclear S1P–S1P1 signaling stimulates Cyr61 
and CTGF transcription in ECs
We next investigated the function of nuclear S1P1 receptor
in ECs. It was shown that S1P treatment results in tran-
scriptional activation of the Cyr61, CTGF, and COX-2
genes (Han et al. 2003; Muehlich et al. 2004; Kim et al.
2003). Because endothelial S1P/S1P1 signaling has been
shown to play a critical role in the regulation of the angio-
genic response (Lee et al. 1999; Liu et al. 2000), we ini-
tially focused on examining whether nuclear S1P1 regulates
the transcriptional activation of Cyr61 and CTGF, two
growth factors implicated in angiogenesis (Leu et al. 2002;
Fig. 6 Ligand-induced intracel-
lular traYcking of S1P1 receptor. 
HEK293S1P1GFP cells were 
transfected with nuclear locali-
zation sequence (NLS) tagged 
YFP polypeptides to locate the 
nuclei (blue). Cultures were se-
rum-starved for 24 h followed 
by stimulating with S1P 
(200 nM). The intracellular 
traYcking of S1P1GFP polypep-
tides (green) was recorded by 
live cell imaging technique as 
we previously described (Jala 
et al. 2005). The micrograms are 
from a representative of seven 
independent experiments which 
have similar results123
246 Histochem Cell Biol (2009) 131:239–249Gao and Brigstock 2004). In agreement with previous stud-
ies, S1P treatment induced Cyr61 and CTGF transcription
in a time-dependent manner in cultured ECs (Fig. 8a). In
this study, we show that S1P1 was redistributed to nuclear
compartment in S1P-treated ECs (Fig. 5). Accordingly,
nuclei isolated from S1P-pre-treated ECs were able to
induce Cyr61 and CTGF expression following S1P stimula-
tion in an in vitro nuclear run-oV transcription assay
(Fig. 8b, c). In contrast, S1P1 receptors were mainly located
at the plasma membrane of serum-starved ECs (Fig. 5).
Consequently, nuclei isolated from serum-starved ECs
failed to induce Cyr61 and CTGF transcription. These data
indicate that the nuclear S1P–S1P1 signaling axis at least in
part regulates S1P-mediated transcription activation of
Cyr61 and CTGF in ECs. Also, plasma membrane S1P1
receptor transduced signaling requires the activity of Gi
heterotrimeric G protein (Lee et al. 1996, 1998, 1999, 2001).
Pretreatment of cells or isolated nuclei with pertussis toxin,
an inhibitor of Gi polypeptides, completely abrogated the
S1P-induced transcription of Cyr61 and CTGF (Fig. 8d). It
suggests that nuclear S1P1 receptors-mediated Cyr61 and
CTGF transcription is also regulated by a Gi-dependent
pathway.
Discussion
Intracellular traYcking plays an important role in GPCRs
signaling and function. Using HEK293 cells expressing
S1P1GFP polypeptides, we showed that S1P treatment
results in the internalization of S1P1 receptors into the intra-
cellular endosomal compartment (Liu et al. 1999). Also, it
was recently demonstrated that S1P1 is relocated to caveo-
lae for regulation of cortical actin formation (Singleton
et al. 2005) and to proteasomes, where the receptor was
ubiquitinylated and degraded (Oo et al. 2007). These results
together suggest that S1P1 may be redistributed to multiple
intracellular organelles to execute distinct signaling path-
ways. Thus, we utilized time-lapse microscope analysis to
examine the S1P-stimulated intracellular traYcking of S1P1
receptors in a spatiotemporal manner (Fig. 6; Supplemental
data 1). Surprisingly, we constantly observed that S1P1
receptors were rapidly internalized into intracellular com-
partments upon ligand stimulation, traveled to nuclear
regions, and then recycled back to plasma membrane
(Fig. 6; Supplemental data 1). This observation suggests
that cellular nucleus may be a novel intracellular destina-
tion of ligand-induced S1P1 traYcking.
Subsequently, we rigorously examined this speculation
by utilizing various biochemical and microscopic tech-
niques. Cellular fractionation studies showed that S1P1
receptors were present in the nuclei of ECs and HEK293
cells stably expressing S1P1GFP polypeptides (Fig. 1). The
isolated nuclear fraction was lack of contaminated polypep-
tides from other cellular compartments (e.g., CD61, Na/K
ATPase for the plasma membrane, Rab4 for the endosome,
and calnexin for endoplasmic reticulum; Fig. 1a, c). More-
over, lamin A/C polypeptides (a speciWc nuclear marker)
were only detected in the isolated nuclear fraction (Fig. 1a,
c). These data suggest that the presence of S1P1 receptors in
the nuclei is not an artifact of isolation. Furthermore, anti-
S1P1 immunogold labeling followed by high resolution
electron microscopic analysis showed that S1P1 receptors
are speciWcally present in both plasma membrane and
nuclear envelop of ECs (Fig. 2). In addition, S1P1 polypep-
tides were clearly present in the nuclei when the isolated
nuclei were examined by confocal microscope analysis
(Fig. 3). Collectively, these data suggest that nuclear pres-
ence of S1P1 receptors is a truly physiological phenomenon.
There are increasing lines of evidence showing the pres-
ence of GPCRs in the nuclear compartment (Marrache et al.
Fig. 7 S1P induces nuclear localization of S1P1 receptors. a
HEK293S1P1GFP cells were labeled with cell impermeable Sulfo-
NHS-SS-Biotin reagent (Pierce) at 4°C for 20 min. Cells were sepa-
rated into nuclear and non-nuclear fractions as described above. Ex-
tracts were incubated with avidin beads to isolate biotin-labeled
polypeptides followed by immunoblotting with GFP or Ran antibody
(top two panels). 3rd–6th panels 50 g extracts were directly probed
with indicated antibodies. Note that the biotinylation condition only la-
bel plasma membrane polypeptides since neither nuclear S1P1 nor Ran
(a cytoplasmic/nuclear polypeptide) was labeled. b After biotinylation,
cells were washed and incubated at 37°C with or without S1P (200 nM)
for various times. Cell nuclei were prepared and nuclear extracts were
incubated with avidin beads. Top panel the avidin beads isolated com-
plexes were blotted with anti-GFP. 2nd–4th panels 50 g extracts were
directly immunoblotted with indicated antibodies. Note that biotin-la-
beled S1P1 receptors were not detected in the nuclei in the absence of
S1P stimulation (left lane, top panel). In contrast, biotin-labeled S1P1
appeared in the nuclear compartment after S1P stimulation (2nd–4th
lanes, top panel). Also note that the amount of nuclear S1P1 receptors
was signiWcantly increased after S1P treatment (second panel). The
experiments in a and b were repeated at least three times with similar
results123
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et al. 2004; Pickard et al. 2006; Liao et al. 2007). The topo-
logical aspects of nuclear GPCRs are completely unknown
at present, because GPCRs are highly hydrophobic due to
their seven trans-membrane segments. Moreover, since the
canonical nuclear localization sequences (NLS) have not
been identiWed in GPCRs, the mechanisms underlying
nuclear translocation of GPCRs have not been deWned.
Immunogold labeling showed that S1P1 receptors are
mainly located at the nuclear envelop region (arrows,
Figs. 2, 5). Thus, it is possible that the structure of nuclear
S1P1 might be stabilized in the nuclei by integration into
nuclear membrane, which is similar to the topological char-
acteristics of plasma membrane S1P1.
SpeciWc nuclear translocation is generally thought to
occur via NLS, which contains either a stretch of basic
amino acids or bipartite clusters of basic amino acids (Sil-
ver 1991; Dingwall and Laskey 1991). A close examination
of the primary sequence of S1P1 polypeptides does not
reveal the presence of such a canonical NLS. Interestingly,
11 of 34 amino acids (32.4%) in the third intracellular loop
(i3 domain) of the S1P1 receptors are either Arg or Lys
(RIYSLVRTRSRRLTFRKNISKGSRSSEKSLALLK). It
suggests that the i3 domain of S1P1 receptor might function
as a non-canonical NLS; and thus, mediate nuclear translo-
cation of S1P1 receptors. However, this notion is highly
speculative and awaits empirical determination by site-
directed mutagenesis of i3 domain of S1P1 receptors in the
future.
It should be noted that the size of the S1P1 receptor in
the nucleus is the same as that in the plasma membrane as
detected by immunoblotting (Fig. 1a), which is consistent
Fig. 8 Induction of Cyr61 and CTGF gene expression by nuclear S1P-
S1P1 signaling. a ECs were treated with S1P for various times. Subse-
quently, the expression of Cyr61 and CTGF transcripts was measured
by RT-PCR as described in Sect. “Materials and methods”; RNA, RT-
PCR reaction was performed in the absence of RNA transcript. b Nu-
clei (Nu) were isolated from ECs pre-treated with or without S1P. Sub-
sequently, the isolated nuclei were stimulated in the presence or
absence of S1P during the in vitro nuclear run-oV transcription reaction
as described in Sect. “Materials and methods”. Cells (2nd and 3rd
lanes), RT-PCR of total RNAs isolated from intact ECs pretreated with
or without S1P for 1 h. c Mean § SE. (n = 3) of in vitro nuclear run-oV
transcription assay of S1P induced Cyr61 and CTGF gene expression
in isolated endothelial nuclei. d Cell, ECs were pretreated with or with-
out pertussis toxin (PTx, 200 ng/ml, 2 h) followed by stimulating with
S1P for 1 h. Nu Nuclei were isolated from S1P-prestimulated cells. The
isolated nuclei were stimulated with or without S1P (1 M) in the pres-
ence or absence of PTx (500 ng/ml) during the in vitro nuclear run-oV
transcription reaction. Data are mean § SE. of two experiments with
duplicate determinants123
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receptor could be detected by either anti-GFP for the C-ter-
minal GFP tag (Figs. 1b, c, 7) or an antibody for the N-ter-
minal Flag tag (data not shown). This data indicates that
nuclear S1P1 has not been proteolytically processed and is
full length during the process of nuclear translocation.
However, it is presently unknown whether subtle modiWca-
tions (e.g., phosphorylation) of S1P1 receptors are required
for nuclear translocation.
Confocal microscopic analysis and live cell imaging
showed that S1P treatment stimulates the translocation of
plasma membrane S1P1 receptors to nuclear compartment
(Figs. 4, 6; supplemental data 1). The ligand-induced plasma
membrane–nucleus traYcking route was further conWrmed
by the membrane biotinylation technique (Fig. 7). We used
the cell impermeable Sulfo-NHS-SS-Biotin reagent to exclu-
sively label the extracellular domains of plasma membrane
polypeptides (Fig. 7a). After ligand stimulation, the biotin-
labeled S1P1 receptors appeared in the isolated nuclei in a
time-dependent manner (top panel, Fig. 7b). Thus, these data
suggest that the nuclear S1P1 was translocated from plasma
membrane after ligand stimulation.
In summary, we show that S1P1 is present in the nuclear
compartment of normal growing ECs. Also, we provide
evidence supporting that S1P stimulation induces the
plasma membrane–nucleus traYcking of S1P1 receptors in
ECs. Importantly, we show that the nuclear S1P–S1P1 sig-
naling axis in ECs directly induces expression of Cyr61 and
CTGF, two growth factors which are functionally implied
in angiogenic responses (Leu et al. 2002; Gao and Brig-
stock 2004). These data together strongly suggest that
nuclear localization of the S1P1 receptor is a truly physio-
logical phenomenon.
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